本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ventyx Biosciences, Inc.

3.60
-0.2610-6.76%
成交量:53.37万
成交额:198.02万
市值:2.57亿
市盈率:-2.15
高:3.88
开:3.88
低:3.56
收:3.86
52周最高:4.05
52周最低:0.7830
股本:7,130.85万
流通股本:5,355.59万
量比:1.39
换手率:1.00%
股息:- -
股息率:- -
每股收益(TTM):-1.6773
每股收益(LYR):-1.9732
净资产收益率:-48.56%
总资产收益率:-30.23%
市净率:1.23
市盈率(LYR):-1.82

数据加载中...

2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/22

重要事件披露

Form 8-K - Current report
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/10

重要事件披露

Form 8-K - Current report
2023/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities